Evaluation of therapeutic effect of Simospan syrup on covid-19

Phase 2

Recruiting

Conditions: covid-19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20210621051642N1

Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 52

Inclusion Criteria

Age limitation (30-60 years old)
Hospitalized patients with CT-scan findings in favor of Covid-19 disease
Hospitalized patients with the amount of blood oxygen saturation below 93%
Hospitalized patients with Chest X-ray findings in favor of pneumonia
Hospitalized patients without underlying disease

Exclusion Criteria

Pregnancy and lactation
End-stage Covid-19 patients
Patients diagnosed with underlying disease and organ damage

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The spent time to illness improvement. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Variable type is qualitative and its scale is nominal.the criterion of recovery records and descripts based on observations of data collecting man in checklist.relative criterion based on clinical symptoms:1-non-admission along with the return of normal activity-2-non-admission along without the return of normal activity-3-admission without the need for oxygentherapy-4-admission with the need for oxygentherapy-5-admission with the need to receive high speed oxygen from the nose or non invasive ventilation or both-6-admission with the need to receive oxygen therapy with invasive ventilation or oxygen therapy from non pulmonary pathways or both-7- patient's death.;Discharge from hospital. Timepoint: After the start of intervention. Method of measurement: Duration of hospitalization.

Secondary Outcome Measures